MICROTECH MED-B (02235) has spent HK$370,400 to repurchase 50,000 shares on April 2nd.
Weitai Medical-B (02235) announced on April 2, 2026 that the company repurchased 50,000 shares for a total of HK$370,400 at a repurchase price of HK$7.35-7.46 per share.
MICROTECH MED-B(02235) announced that on April 2, 2026, the company spent 370,400 Hong Kong dollars to repurchase 50,000 shares at a repurchase price of 7.35-7.46 Hong Kong dollars per share.
Related Articles
China Sanjiang (02198): Sanjiang Chemical and Blue Whale Bio-energy signed a naphtha purchase agreement.
ZERO2IPO (01945) spent HK$123,500 to repurchase 74,400 shares on April 2nd.
Peg Bio-Pharmaceuticals-B (02565): CR059 selected as a breakthrough in the latest abstract of the ADA 2026 Annual Meeting, innovative strength recognized again.
China Sanjiang (02198): Sanjiang Chemical and Blue Whale Bio-energy signed a naphtha purchase agreement.
ZERO2IPO (01945) spent HK$123,500 to repurchase 74,400 shares on April 2nd.
Peg Bio-Pharmaceuticals-B (02565): CR059 selected as a breakthrough in the latest abstract of the ADA 2026 Annual Meeting, innovative strength recognized again.
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026
